Technical Analysis for ORPH - Open Orphan Plc

Grade Last Price % Change Price Change
grade F 5.15 -10.82% -0.63
ORPH closed down 10.82 percent on Monday, December 9, 2019, on 9.54 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
See historical ORPH trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Reversal New Lows Setup Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Older signals for ORPH ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Venn Life Sciences Holdings plc is a clinical research organization (CRO), which is engaged in providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology and medical device organizations. The Company has the innovation segment, which is focused on developing and commercializing skin technologies. It provides drug development services through its subsidiary, Kinesis Pharma B.V. The Company's drug development services include clinical development, pharmaceutical development, non-clinical/pre-clinical development, drug candidate selection and drug development project management. The Company offers international clinical research services, including protocol development; feasibility and site selection; investigator and site selection; project management; site management and monitoring; vendor management, and quality assurance. The Company has its presence in the United Kingdom, Ireland, France, Netherlands, Germany and Singapore.
Articles Biotechnology Health Project Management Pharmaceutical Industry Drug Discovery Drug Development Clinical Trial Clinical Research Contract Research Organizations Parexel Clinical Research Services Drug Development Services Pharmaceutical Development Site Management Clinical Trial Services Dokumeds Drug Development Project Management Medical Statistics Skin Technologies Vendor Management

Is ORPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 8.15
52 Week Low 4.799
Average Volume 586,045
200-Day Moving Average 0.00
50-Day Moving Average 6.24
20-Day Moving Average 6.19
10-Day Moving Average 6.01
Average True Range 0.25
ADX 21.96
+DI 10.26
-DI 42.84
Chandelier Exit (Long, 3 ATRs ) 5.83
Chandelier Exit (Short, 3 ATRs ) 5.54
Upper Bollinger Band 6.79
Lower Bollinger Band 5.58
Percent B (%b) -0.35
BandWidth 19.67
MACD Line -0.17
MACD Signal Line -0.07
MACD Histogram -0.0988
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.73
Resistance 3 (R3) 6.78 6.32 6.46
Resistance 2 (R2) 6.32 5.92 6.29 6.38
Resistance 1 (R1) 5.73 5.67 5.50 5.68 6.29
Pivot Point 5.27 5.27 5.15 5.24 5.27
Support 1 (S1) 4.68 4.86 4.45 4.62 4.01
Support 2 (S2) 4.22 4.62 4.19 3.92
Support 3 (S3) 3.63 4.22 3.84
Support 4 (S4) 3.57